ArticleHealthcare (Basel, Switzerland)2024

Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).

Valeria Dipasquale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.